These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1047 related articles for article (PubMed ID: 28576475)

  • 1. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
    Kakihana K
    Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.
    Schwabkey ZI; Jenq RR
    Annu Rev Med; 2020 Jan; 71():137-148. PubMed ID: 31986084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional interventions in patients with graft-versus-host disease.
    Seguy D; Hueso T
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):455-462. PubMed ID: 37389472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and allogeneic transplantation.
    Wang W; Xu S; Ren Z; Jiang J; Zheng S
    J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation.
    Raghunathan VM; Sheng I; Lim SH
    J Transl Med; 2016 Dec; 14(1):335. PubMed ID: 27912759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.
    Riwes M; Reddy P
    Semin Hematol; 2020 Jan; 57(1):1-6. PubMed ID: 32690138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.